CERAD – Center for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals.

The project concerns the establishment of the "CERAD" Center for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals - a strategic research infrastructure included in the list of the Polish Road Map for Research Infrastructure. The planned infrastructure will be used both non-economically and economically. The project is implemented by a consortium headed by the Applicant - the National Center for Nuclear Research (hereinafter NCBJ) - Consortium Leader and the only beneficiary of aid and consortium members - the University of Warsaw, the Institute of Nuclear Chemistry and Technology, the Medical University of Warsaw, the Jagiellonian University, Collegium Medicum and the Medical University of Bialystok. The aim of the project is to create a modern research infrastructure in the field of searching for new radiopharmaceuticals for diagnostics and therapy, based on biologically active ligands operating at the cellular and molecular level. The combination of isotope techniques with molecular markers of the disease state will enable earlier detection of diseases and implementation of appropriate therapeutic procedures. The implemented Project is therefore a response to the global socio-demographic trends and challenges related to the development of effective methods of cancer diagnostics and therapy.